Dr Sud Speaks, page-25

Well said.

I’ve witnessed first hand the significant impact of CBD on chronic pain. It’s not hyperbole to state it’s a life changing compound and importantly reduces the potential burden and addiction associated with opioids.

The ARDS, OSA and TBI clinical trials have the potential to not only change lives but also create substantial upside for shareholders. Once again, GW Pharma is the benchmark, both in terms of a life changing drug and also economic return.

If one of the IHL trials creates a genuine drug discovery the share price will explode IMO.

And it appears some very serious money (Glenn Poswell) thinks so too...